Assyro AI

Orange Book product · Brand (NDA)

TEPADINA AND SODIUM CHLORIDE

THIOTEPA

Brand (NDA)NDA 208264RX ADIENNE SA

At a glance

Apr 10, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 10, 2025

    1 yr 3 mo ago

  2. Today

  3. Patent 9931458 expires

    Listed drug product patent expiration.

    May 31, 2037

    in 11 yr 1 mo

Pharmaceutical detail

Active ingredient

THIOTEPA

Strength

200MG

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 208264

Product number

003

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9931458May 31, 2037in 11 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.